NCT04911751CompletedPhase 2
A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis
Source: ClinicalTrials.gov · Last updated 7 Jan 2025
Brief summary (registry, in English)
The study is designed to investigate efficacy and safety of KBL697 in patients with Moderate Plaque Type Psoriasis. KBL697 has been developed as a potential new treatment for Psoriatic Plaque.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 9 May 2021
- Start date
- 8 Nov 2021
- Primary completion date
- 8 Nov 2023
- Lead sponsor
- KoBioLabs
- Diseases
- Psoriasis
- NCT number
- NCT04911751
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 80
- From 8 Nov 2021 to the primary completion date, 8 Nov 2023
- 10 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Drug-induced psoriasis
- Medicinal shampoos that contain tar and/or salicylic acid within 2 weeks prior to Baseline Visit
Other illness
- Other inflammatory skin disease that may confound the evaluation of plaque psoriasis
Other
- Current diagnosis of forms of psoriasis other than chronic plaque type only
- Failed 2 or more systemic treatments for plaque psoriasis
Who the study is looking for
- Male or female, aged 18 to 75 years (inclusive)
- Have a diagnosis of plaque type psoriasis for ≥ 6 months
- Must have chronic plaque type psoriasis of moderate severity
- All subjects must agree and commit to the use of a reliable contraceptive regimen.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (10)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sinclair Dermatology Coordinator of this site? Confirm its status | East Melbourne | Australia | Unknown status |
| Premier Specialist Coordinator of this site? Confirm its status | Kogarah | Australia | Unknown status |
| Westmead Hospital Coordinator of this site? Confirm its status | Westmead | Australia | Unknown status |
| Veracity Clinical Trials Ltd Coordinator of this site? Confirm its status | Woolloongabba | Australia | Unknown status |
| Louisiana Dermatology Associates - Dermatology Coordinator of this site? Confirm its status | Baton Rouge | United States | Unknown status |
| Total Skin and Beauty Dermatology Center Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
| Revival Research Institute Coordinator of this site? Confirm its status | Doral | United States | Unknown status |
| Indago Research and Health Center Coordinator of this site? Confirm its status | Hialeah | United States | Unknown status |
| Southern California Dermatology, Inc. Coordinator of this site? Confirm its status | Santa Ana | United States | Unknown status |
| Clinical Science Institute Coordinator of this site? Confirm its status | Santa Monica | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.